LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-6.40 Cr | ₹-5.18 Cr | ₹-4.50 Cr | ₹-2.56 Cr | ₹-5.75 Cr |
What is the latest Cash Flow from Financing Activities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-6.40 Cr |
| Mar2024 | ₹-5.18 Cr |
| Mar2023 | ₹-4.50 Cr |
| Mar2022 | ₹-2.56 Cr |
| Mar2021 | ₹-5.75 Cr |
How is Cash Flow from Financing Activities of LINCOLN PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-6.40 Cr | Negative | |
| Mar2024 | ₹-5.18 Cr | Negative | |
| Mar2023 | ₹-4.50 Cr | Negative | |
| Mar2022 | ₹-2.56 Cr | Negative | |
| Mar2021 | ₹-5.75 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,161.0 Cr | -2.8% | -3.3% | 3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -2.8% |
-3.3% |
3.9% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses